ELECTROFOCUSING PATTERNS OF FUCOSYLTRANSFERASES IN PLASMA OF PATIENTS WITH NEOPLASTIC DISEASEKESSEL D; RATANATHARATHORN V; TA HSU CHOU et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 9; PP. 3377-3380; BIBL. 19 REF.Article

PHASE II TRIAL OF DIANHYDROGALACTITOL IN ADVANCED RENAL CELL CARCINOMA: A SOUTHWEST ONCOLOGY GROUP STUDYRATANATHARATHORN V; BAKER LH; BALDUCCI L et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 5; PP. 1231-1232; BIBL. 1 REF.Article

Tacrolimus : a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantationJACOBSON, P; UBERTI, J; DAVIS, W et al.Bone marrow transplantation (Basingstoke). 1998, Vol 22, Num 3, pp 217-225, issn 0268-3369Article

Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantationYANIK, G; LEVINE, J. E; RATANATHARATHORN, V et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 2, pp 161-167, issn 0268-3369Article

Bone metastasis : Review and critical analysis of random allocation trials of local field treatmentRATANATHARATHORN, V; POWERS, W. E; MOSS, W. T et al.International journal of radiation oncology, biology, physics. 1999, Vol 44, Num 1, pp 1-18, issn 0360-3016Article

Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide (MAC) in stage III and IV ovarian cancer = Association de mitomycine C, adriamycine, et cyclo-phosphamide dans les cancers stades III et IV de l'ovaireRATANATHARATHORN, V; SAMSON, M. K; BAKER, L. H et al.American journal of clinical oncology. 1983, Vol 6, Num 5, pp 565-570, issn 0277-3732Article

Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomesUBERTI, J. P; AYASH, L; BRAUN, T et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 5, pp 425-431, issn 0268-3369, 7 p.Article

Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantationCRONIN, S; UBERTI, J. P; AYASH, L. J et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 11, pp 1247-1249, issn 0268-3369Article

Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation : CD34⁺ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cellsCHOI, D; PERRIN, M; HOFFMANN, S et al.Clinical cancer research. 1998, Vol 4, Num 11, pp 2709-2716, issn 1078-0432Article

Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipientsWINGARD, J. R; NASH, R. A; FITZSIMMONS, W et al.Bone marrow transplantation (Basingstoke). 1997, Vol 20, Num 1, pp 49-51, issn 0268-3369Article

Repeated course of rituximab for treatment of nephrotic syndrome in patients with chronic GVHDMELLON-REPPEN, S; RATANATHARATHORN, V; CRONIN, S et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 12, pp 1758-1759, issn 0268-3369, 2 p.Article

Salvage treatment for sarcomas of the handVISUTHIKOSOL, V; KRUAVIT, A; NITIYANANT, P et al.Annals of plastic surgery. 1998, Vol 40, Num 6, pp 637-640, issn 0148-7043Article

Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasiaUBERTI, J. P; AGOVI, M.-A; COPELAN, E et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 1, pp 34-43, issn 0268-3369, 10 p.Article

Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with ^99mTc scintigraphySIRISRIRO, R; BOONKITTICHAROEN, V; JALAYONDEJA, V et al.Hepato-gastroenterology. 2000, Vol 47, Num 32, pp 405-413, issn 0172-6390Article

Osteosarcoma : A study of 130 casesPOCHANUGOOL, L; SUBHADHARAPHANDOU, T; HATHIRAT, P et al.Chot Mai Het Thang Phaet. 1997, Vol 80, Num 3, pp 153-159, issn 0125-2208Article

Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignanciesUBERTI, J. P; SILVER, S. M; ADAMS, P. T et al.Bone marrow transplantation (Basingstoke). 1997, Vol 19, Num 12, pp 1233-1238, issn 0268-3369Article

Transplantation in patients with multiple myeloma : A multicenter comparative analysis of peripheral blood stem cell and allogeneic transplantVARTERASIAN, M; JANAKIRAMAN, N; ADAMS, P. T et al.American journal of clinical oncology. 1997, Vol 20, Num 5, pp 462-466, issn 0277-3732Article

Graft failure in children receiving HLA-mismatched marrow transplants with busulfan-containing regimensSCHULTZ, K. R; RATANATHARATHORN, V; ABELLA, E et al.Bone marrow transplantation (Basingstoke). 1994, Vol 13, Num 6, pp 817-822, issn 0268-3369Article

Coactivation with anti-CD28 monoclonal antibody enhances anti-CD3 monoclonal antibody-induced proliferation and IL-2 synthesis in T cells from autologous bone marrow transplant recipientsLUM, L. G; JOSHI, I. D; JUNE, C. H et al.Bone marrow transplantation (Basingstoke). 1993, Vol 12, Num 6, pp 565-571, issn 0268-3369Article

Long-term follow up of patients proceeding to transplant using plerixafor mobilized stem cells and incidence of secondary myelodysplastic syndrome/AMLDEOL, A; ABRAMS, J; MASOOD, A et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 8, pp 1112-1116, issn 0268-3369, 5 p.Article

Do negative or positive emotions differentially impact mortality after adult stem cell transplant?HOODIN, F; UBERTI, J. P; LYNCH, T. J et al.Bone marrow transplantation (Basingstoke). 2006, Vol 38, Num 4, pp 255-264, issn 0268-3369, 10 p.Article

West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantationREDDY, P; DAVENPORT, R; RATANATHARATHORN, V et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 1, pp 109-112, issn 0268-3369, 4 p.Article

Chronic graft-versus-host disease: clinical manifestation and therapyRATANATHARATHORN, V; AYASH, L; LAZARUS, H. M et al.Bone marrow transplantation (Basingstoke). 2001, Vol 28, Num 2, pp 121-129, issn 0268-3369Article

A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host diseasePRZEPIORKA, D; PHILLIPS, G. L; RATANATHARATHORN, V et al.Blood. 1998, Vol 92, Num 11, pp 4066-4071, issn 0006-4971Article

Ondansetron: prevention of nausea and vomiting in cisplatin based chemotherapyCHEIRSILPA, A; RATANATHARATHORN, V; SINLARAT, P et al.Chot Mai Het Thang Phaet. 1994, Vol 77, Num 4, pp 201-206, issn 0125-2208Article